FOI release

Puberty blockers

Some or all of the information requested was not provided because we determined that the cost to do so would exceed the appropriate limit.

Case reference FOI2026/00186

Received 20 February 2026

Published 9 March 2026

Request

I would like to request information on the following: 1) Any internal correspondence relating to the proposed puberty blockers trial 2) The names of the members of the panel who made the decision to write a letter on behalf of the MHRA expressing concern about the proposed puberty blockers trial

Response

See attached

Documents

• FOI2026_00186 (redacted).pdf (616.5 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.